Skip to main content
SpringerLink
Log in

Hope for a pharmacological male contraceptive

  • New Drugs and Therapeutics
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Matlin SA. Prospects for pharmacological male contraception. Drugs 1994; 48: 851–63

    Article  PubMed  CAS  Google Scholar 

  2. Matsumoto AM. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone and sperm production. J Clin Endocrinol Metab 1990; 70: 282–7

    Article  PubMed  CAS  Google Scholar 

  3. Wallace EM, Gow SM, Wu FCW. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study I: plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations. J Clin Endocrinol Metab 1993; 77: 290–3

    Article  PubMed  CAS  Google Scholar 

  4. World Health Organisation Task Force on Methods for the Regulation of Male Fertility. Contraceptive efficacy of testosterone-induced azoospermia in normal men. Lancet 1990; 336: 955–9

    Article  Google Scholar 

  5. Behre HM, Nieschlag E. Testosterone buciclate (20 Aet-1) in hypogonadal men: pharmacokinetics and pharmacodynamics of the new long-acting androgen ester. J Clin Endocrinol Metab 1992; 75: 1204–10

    Article  PubMed  CAS  Google Scholar 

  6. Sundaram K, Kumar N, Bardin CW. 7α-Methyl-nortestosterone (MENT): the optimal androgen for male contraception. Ann Med 1993; 25: 199–205

    Article  PubMed  CAS  Google Scholar 

  7. Barfield A, Melo J, Coutinho E, et al. Pregnancies associated with sperm concentrations below 10 million/ml in clinical studies of potential male contraceptive method, monthly depot medroxyprogesterone acetate and testosterone esters. Contraception 1979; 20: 121–127

    Article  PubMed  CAS  Google Scholar 

  8. Matsumoto AM. Is high dosage testosterone an effective male contraceptive agent? Fertil Steril 1988; 50: 324–8

    PubMed  CAS  Google Scholar 

  9. Wallace EM, Aitken RJ, Wu FCW. Residual sperm function in oligospermia induced by testosterone enanthate administered as a potential steroid male contraceptive. Int J Androl 1992; 15: 214–6

    Article  Google Scholar 

  10. World Health Organization. Comparison of two androgens plus depot-me-droxyprogesterone acetate for suppression to azoospermia in Indonesian men. Fertil Steril 1993; 60: 1062–8

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hope for a pharmacological male contraceptive. Drugs Ther. Perspect 5, 7–8 (1995). https://doi.org/10.2165/00042310-199505080-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199505080-00003

Keywords

Search

Navigation